Home LiteratureArticle Details
PMID: 7536816 Published · ppublish English Journal Article

Treatment with basic fibroblastic growth factor following focal cerebral ischemia does not prevent neuronal injury.

Journal of the neurological sciences ·Vol. 128 ·No. 1 ·1995-01-00 ·Pages 66-70

Tenjin H, Anderson RE, Meyer FB

Abstract

This experiment determined if postischemic administration of basic fibroblast growth factor (bFGF) would result in neovascularization to minimize neuronal injury following a focal cerebral ischemia insult. Fifty-eight Sprague-Dawley rats underwent middle cerebral artery (MCA) occlusion and were divided into three groups receiving either vehicle, serum, or 50 ng bFGF biweekly through an indwelling ventricular cannula. At variable time intervals, the animals underwent carbon black perfusion of capillary beds and histological staining for assessment of neuronal injury. Following MCA occlusion, there was a significant decrease in capillary bed density in peri-infarction cortex which normalized by two weeks. The number of alive neurons in the peri-infarction cortex was also significantly decreased compared to contralateral control cortex. The chronic administration of bFGF commencing two days after MCA occlusion did not result in either a significant increase in capillary bed density or the number of alive neurons in the peri-infarction cortex.

MeSH Terms
Animals Brain Ischemia/drug therapy,pathology Capillaries/pathology Cerebral Arteries/physiology Fibroblast Growth Factor 2/administration & dosage,therapeutic use Injections, Intraventricular Male Neovascularization, Pathologic/pathology Neurons/drug effects Rats Rats, Sprague-Dawley Time Factors
Chemicals
Fibroblast Growth Factor 2
Authors & Affiliations
3 authors, click to expand affiliations / ORCID
Tenjin H
Department of Neurosurgery, Mayo Clinic, Rochester, MN 55905, USA.
Anderson R E
Meyer F B
Article Info
Journal
Journal of the neurological sciences
Abbr.
J Neurol Sci
ISSN
0022-510X
Published
1995-01-00
Pages
66-70
Language
English
Region
Netherlands
NLM ID
0375403
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com